SCHEMBL19400

SCHEMBL19400

[C]1Nc2ccccc2S1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL582683 1.00 — —
SCHEMBL7172665 0.76 GAA (0.39) —
SCHEMBL23127930 0.70 — —
SCHEMBL2704673 0.68 GAA (0.41) —
SCHEMBL331758 0.67 GAA (0.39) —
SCHEMBL155144 0.65 GAA (0.48) —
SCHEMBL11286921 0.65 ALDH1A1 (0.44) —
SCHEMBL3469293 0.65 ALDH1A1 (0.44) —
SCHEMBL207246 0.65 GAA (0.38) —
SCHEMBL10648460 0.64 NOX1 (0.46) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2238 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11987588-B2 Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of heart failure and disorders related thereto ARENA PHARMACEUTICALS, INC. (US) 2024-05-21 — — US claimed
WO-2023185986-A1 BCL-XL INHIBITORS BEIGENE , LTD. (KY) 2023-10-05 — — WO claimed
EP-3720858-B1 MODULATORS OF THE BETA-3 ADRENERGIC RECEPTOR USEFUL FOR THE TREATMENT OR PREVENTION OF HEART FAILURE AND DISORDERS RELATED THERETO ARENA PHARM INC (US) 2023-06-07 — — EP claimed
EP-4149929-A1 TRIAZINE AND PYRIMIDINE (THIO)AMIDES AS FUNGICIDAL COMPOUNDS Bayer Aktiengesellschaft (DE) 2023-03-22 — — EP claimed
CN-108430972-B Alpha, beta-unsaturated amide compound 协和麒麟株式会社 2022-12-27 — — CN claimed
US-20220396579-A1 MODULATORS OF THE BETA-3 ADRENERGIC RECEPTOR USEFUL FOR THE TREATMENT OR PREVENTION OF HEART FAILURE AND DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. 2022-12-15 — — US claimed
US-20220396553-A1 NOVEL HYDRAZONE DERIVATIVE IN WHICH TERMINAL AMINE GROUP IS SUBSTITUTED WITH ARYL GROUP OR HETEROARYL GROUP, AND USE THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2022-12-15 — — US claimed
US-20220396571-A1 SPIROPIPERIDINE ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS MERCK SHARP & DOHME CORP. (US) 2022-12-15 — — US claimed
CN-113727972-A Novel hydrazone derivatives in which terminal amino group is substituted with aryl or heteroaryl group, and use thereof 韩国科学技术研究院 2021-11-30 — — CN claimed
WO-2021228734-A1 TRIAZINE AND PYRIMIDINE (THIO)AMIDES AS FUNGICIDAL COMPOUNDS BAYER AKTIENGESELLSCHAFT (DE) 2021-11-18 — — WO claimed
EP-0297872-A2 Novel polymethine dyes and UV absorbers and imaging materials for their use EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1989-01-04 — — EP claimed
EP-0297871-A2 Novel polymethine dyes and UV absorbers and imaging materials for their use EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1989-01-04 — — EP claimed
US-4628061-A Prostaglandins NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1986-12-09 — — US claimed
US-4618617-A ANTIINFLAMMATORY, ANALGESIC AGENTS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1986-10-21 — — US claimed
US-4596823-A Prostaglandins NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1986-06-24 — — US claimed
US-4576905-A Photographically useful chalcogenazoles, chalcogenazolines, and chalcogenazolinium and chalcogenazolium salts EASTMAN KODAK COMPANY (US) 1986-03-18 — — US claimed
US-4575483-A FACILITATE IMAGE FORMATION EASTMAN KODAK COMPANY (US) 1986-03-11 — — US claimed
EP-0138362-A2 Photographic materials containing chalcogenazoles, chalcogenazolines and chalcogenazolinium and chalcogenazolium salts EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1985-04-24 — — EP claimed
EP-0136847-A2 Photographically useful chalcogenazolylidene and chalcogenazolium dyes and methods for their preparation EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1985-04-10 — — EP claimed
US-4113867-A ANTHELMINTICS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1978-09-12 — — US claimed
Send feedback